125 related articles for article (PubMed ID: 23553334)
1. Assessment of p38α in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma.
Gill K; Kumar R; Mohanti BK; Dey S
Clin Transl Oncol; 2013 Nov; 15(11):969-73. PubMed ID: 23553334
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same.
Sahu V; Nigam L; Agnihotri V; Gupta A; Shekhar S; Subbarao N; Bhaskar S; Dey S
Cancer Res Treat; 2019 Jan; 51(1):313-325. PubMed ID: 29747487
[TBL] [Abstract][Full Text] [Related]
3. Quantification of p38αMAP kinase: a prognostic marker in HNSCC with respect to radiation therapy.
Gill K; Mohanti BK; Ashraf MS; Singh AK; Dey S
Clin Chim Acta; 2012 Jan; 413(1-2):219-25. PubMed ID: 21982916
[TBL] [Abstract][Full Text] [Related]
4. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
[TBL] [Abstract][Full Text] [Related]
5. The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer.
Gill K; Mohanti BK; Singh AK; Mishra B; Dey S
Cancer Biomark; 2011-2012; 10(3-4):125-34. PubMed ID: 22674298
[TBL] [Abstract][Full Text] [Related]
6. Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38alpha MAP kinase.
Gill K; Singh AK; Kapoor V; Nigam L; Kumar R; Holla P; Das SN; Yadav S; Subbarao N; Mohanti BK; Dey S
Biochim Biophys Acta; 2013 Mar; 1830(3):2763-9. PubMed ID: 23238519
[TBL] [Abstract][Full Text] [Related]
7. Induction of ZCCHC6 expression in peripheral blood mononuclear cells by HNSCC secretions.
Arayataweegool A; Srisuttee R; Bin-Alee F; Mahattanasakul P; Tangjaturonrasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
Gene; 2020 Sep; 754():144880. PubMed ID: 32526260
[TBL] [Abstract][Full Text] [Related]
8. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.
Banerjee J; Pradhan R; Gupta A; Kumar R; Sahu V; Upadhyay AD; Chaterjee P; Dwivedi S; Dey S; Dey AB
Clin Transl Oncol; 2017 May; 19(5):571-578. PubMed ID: 27815686
[TBL] [Abstract][Full Text] [Related]
9. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
12. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study.
Sakhi AK; Russnes KM; Thoresen M; Bastani NE; Karlsen A; Smeland S; Blomhoff R
BMC Cancer; 2009 Dec; 9():458. PubMed ID: 20025747
[TBL] [Abstract][Full Text] [Related]
13. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
14. Inverse immunological responses induced by allergic rhinitis and head and neck squamous cell carcinoma.
Millrud CR; Hylander T; Kumlien Georen S; Kågedal Å; Winqvist O; Cardell LO
PLoS One; 2014; 9(1):e86796. PubMed ID: 24466243
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
[TBL] [Abstract][Full Text] [Related]
19. The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.
Gill K; Nigam L; Singh R; Kumar S; Subbarao N; Chauhan SS; Dey S
PLoS One; 2014; 9(7):e101525. PubMed ID: 24983631
[TBL] [Abstract][Full Text] [Related]
20. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma.
Braakhuis BJ; Graveland AP; Dijk F; Ylstra B; van Wieringen WN; Leemans CR; Brakenhoff RH
Oral Dis; 2013 Jul; 19(5):452-5. PubMed ID: 23034102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
